Literature DB >> 7616236

Identification of the 5-hydroxytryptamine2C receptor as a 60-kDa N-glycosylated protein in choroid plexus and hippocampus.

D Abramowski1, M Staufenbiel.   

Abstract

The rat 5-hydroxytryptamine2C (5-HT2C) receptor was identified as N-glycosylated polypeptide of 60-kDa apparent molecular mass using antibodies against its putative third and fourth (C-terminal) cytoplasmic domain. To show that the polypeptides detected on western blots and by immunoprecipitation represent the 5-HT2C receptor, binding studies of the 5-HT2C ligand [3H]-mesulergine to immunoprecipitates from extracts of pig choroid plexus were performed. We demonstrate the presence of a signal sequence that was cleaved off during membrane insertion resulting in a 38-kDa polypeptide. During further maturation, the receptor was N-glycosylated at two sites via a 48-kDa intermediate. This intermediate was far more abundant in choroid plexus than in hippocampus and may represent an intracellular receptor reserve. After transfection of 5-HT2C cDNAs into cultured cells, polypeptides were observed that differed from the ones found in vivo due to abnormal N-glycosylation and possibly other alterations depending on the system used. Thus the 5-HT2C receptor expressed in cell lines may also differ in function from the receptor in its native tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616236     DOI: 10.1046/j.1471-4159.1995.65020782.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Serotonin 5-HT2C receptor protein expression is enriched in synaptosomal and post-synaptic compartments of rat cortex.

Authors:  Noelle C Anastasio; Maria Fe Lanfranco; Marcy J Bubar; Patricia K Seitz; Sonja J Stutz; Andrew G McGinnis; Cheryl S Watson; Kathryn A Cunningham
Journal:  J Neurochem       Date:  2010-03-24       Impact factor: 5.372

2.  Development of the 5-HT2CR-Tango System Combined with an EGFP Reporter Gene.

Authors:  Yoshihisa Watanabe; Atsushi Tsujimura; Miku Aoki; Katsutoshi Taguchi; Masaki Tanaka
Journal:  J Mol Neurosci       Date:  2015-09-15       Impact factor: 3.444

3.  Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors.

Authors:  H Yang; D Lu; G P Vinson; M K Raizada
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

Review 4.  Limitations in anti-obesity drug development: the critical role of hunger-promoting neurons.

Authors:  Marcelo O Dietrich; Tamas L Horvath
Journal:  Nat Rev Drug Discov       Date:  2012-08-03       Impact factor: 84.694

5.  Genetic variation in HTR4 and lung function: GWAS follow-up in mouse.

Authors:  John S House; Huiling Li; Laura M DeGraff; Gordon Flake; Darryl C Zeldin; Stephanie J London
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

6.  Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor.

Authors:  E P Pälvimäki; B L Roth; H Majasuo; A Laakso; M Kuoppamäki; E Syvälahti; J Hietala
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

7.  Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology.

Authors:  C Sturchler-Pierrat; D Abramowski; M Duke; K H Wiederhold; C Mistl; S Rothacher; B Ledermann; K Bürki; P Frey; P A Paganetti; C Waridel; M E Calhoun; M Jucker; A Probst; M Staufenbiel; B Sommer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

8.  5-HT2 Receptor Regulation of Mitochondrial Genes: Unexpected Pharmacological Effects of Agonists and Antagonists.

Authors:  Jennifer L Harmon; Lauren P Wills; Caitlin E McOmish; Elena Y Demireva; Jay A Gingrich; Craig C Beeson; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2016-01-19       Impact factor: 4.030

Review 9.  The serotonin 5-HT7 receptors: two decades of research.

Authors:  Evelien Gellynck; Karen Heyninck; Kjetil W Andressen; Guy Haegeman; Finn Olav Levy; Peter Vanhoenacker; Kathleen Van Craenenbroeck
Journal:  Exp Brain Res       Date:  2013-09-17       Impact factor: 1.972

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.